Comparison of Amla and Standard treatment along with mouth opening exercise in the treatment of Oral Submucous Fibrosis

Comparative Efficacy of Emblica officinalis (Amla) and combination of (Antioxidants and Topical Steroids) along with Physiotherapy in the Management of Oral Submucous Fibrosis: A Clinical Study. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092406

Enrollment

Registered

2025-08-05

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients aged between 20-40 years of either gender, with clinically diagnosed Oral Submucous Fibrosis 2. Patients with mouth opening greater than 30mm (Group A and Group B) according to Lai DR 1995 3. Patients who have not taken any treatment earlier for Oral Submucous Fibrosis 4. Patients who are ready to quit the associated habits and willing to participate in the study with regular follow up visits

Exclusion criteria

Exclusion criteria: 1.Patients with any other associated disease such as Oral Lichen Planus and Oral leukoplakia 2. Patient with any systemic/chronic debilitating diseases and who are on long term medications 3. Pregnant and lactating mothers

Design outcomes

Primary

Measure	Time frame
Burning sensation, Interincisal mouth opening and Cheek flexibilityTimepoint: Day 0 (baseline), Day 15, Day 30, Day 45, Day 60, Day 75, Day 90	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Pallavi Harshad Joshi

Bharati Vidyapeeth Deemed to be University Dental College And Hospital, Pune.

manjula.hebbale@bharatividyapeeth.edu9890178089

Outcome results